ArticleOncoTargets and therapy2022
The Silencing of LncRNA-H19 Decreases Chemoresistance of Human Glioma Cells to Temozolomide by Suppressing Epithelial-Mesenchymal Transition via the Wnt/β-Catenin Pathway [Retraction].
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.